Morlupo, Italy

Riccardo Pezzi

This inventor holds 1 USPTO granted patent. Top assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Riccardo Pezzi. Retrieved from https://idiyas.com/inventor/riccardo-pezzi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Riccardo Pezzi: Innovator in Anti-Tumor Agents

Introduction

Riccardo Pezzi is a notable inventor based in Morlupo, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-tumor agents. His work focuses on innovative compounds that have the potential to improve cancer treatment.

Latest Patents

Riccardo Pezzi holds a patent for "Cinnamic, phenylpropiolic and phenylpropanoic acid derivatives useful as anti-tumor agents." This patent describes cinnamic and phenylpropiolic acid derivatives that exhibit antitumor and chemo-sensitizing activity. The pharmaceutical compositions containing these compounds are designed for the treatment of tumors, showcasing Pezzi's commitment to advancing cancer therapies.

Career Highlights

Pezzi is associated with Sigma-Tau Industrie Farmaceutiche Riunite S.p.a., where he continues to contribute to pharmaceutical innovations. His work has been instrumental in developing new therapeutic options for patients battling cancer.

Collaborations

Throughout his career, Riccardo Pezzi has collaborated with esteemed colleagues such as Claudio Pisano and Gianfranco Battistuzzi. These partnerships have fostered a collaborative environment that enhances the research and development of effective pharmaceutical solutions.

Conclusion

Riccardo Pezzi's innovative work in the field of anti-tumor agents highlights his dedication to improving cancer treatment. His contributions through patents and collaborations reflect his significant impact on pharmaceutical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…